Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0SZI stock hub

LON/0SZI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0SZIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

142.7M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0SZI

In the news

Latest news · LON/0SZI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-54.2

P25 -54.2P50 2.1P75 13.7

ROIC-36.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0SZI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

USD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	36
Employees Change	8%
Employees Change Percent	28.57
Enterprise value	$24M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US21833P3010
Last refreshed	2026-05-10
Market cap	$142.7M
Price	$10.95
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	lon/0SZI
Website	https://www.corbuspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.9%
EV Earnings	-0.41x
EV/FCF	-0.5x
FCF yield	-33.59%
P/B ratio	1.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-52.1M
Net Income	$-58.4M
Net Income Growth Years	0%
Profit Per Employee	$-1.6M
ROA	-32.91
Roa5y	-36.78
ROCE	-57.84
ROE	-54.18
Roe5y	-123.7
ROIC	-36.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	74.71%
Cagr3y	6.06%
Cagr5y	-25.5%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$125M
Cash	$121.3M
Current Assets	$122.5M
Current Liabilities	$15.2M
Debt	$1.2M
Debt Equity	$0.01
Debt FCF	$-0.03
Equity	$109.6M
Liabilities	$15.4M
Long Term Assets	$2.5M
Long Term Liabilities	$196,284
Net Cash	$120.1M
Net Cash By Market Cap	$84.18
Net Cash Growth	10.84%
Net Debt Equity	$-1.1
Tangible Book Value	$109.6M
Tangible Book Value Per Share	$6.22
WACC	18.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.07
Net Working Capital	$-11.4M
Quick ratio	7.96
Working Capital	$108.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	74.64%
200-day SMA	10.28
3Y total return	19.31%
50-day SMA	9.59
50-day SMA vs 200-day SMA	50under200
5Y total return	-77.04%
All Time High	255.1
All Time High Change	-95.71%
All Time High Date	2020-06-24
All Time Low	2.17
All Time Low Change	404.61%
All Time Low Date	2023-03-13
ATR	0.75
Beta	2.68
Ch YTD	34.36
High	11.35
High52	24.5
High52 Date	2025-10-20
High52ch	-55.31%
Low	10.83
Low52	6.34
Low52 Date	2025-05-08
Low52ch	72.82%
Ma50ch	14.21%
Price vs 200-day SMA	6.56%
RSI	59.8
RSI Monthly	45.26
RSI Weekly	56.21
Sharpe ratio	0.84x
Sortino ratio	1.33
Total Return	-22%
Tr YTD	34.36
Tr1m	6.83%
Tr1w	11.22%
Tr3m	39.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-63.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,741,478%
Shares Insiders	0.55%
Shares Institutions	46.57%
Shares Qo Q	33.93%
Shares Yo Y	22%
Short Ratio	5.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-52.6M
Average Volume	1,642.95x
Bv Per Share	6.22
CAPEX	$-5,201
Ch1m	6.83
Ch1w	11.22
Ch1y	74.64
Ch3m	39.54
Ch3y	19.31
Ch5y	-77.04
Ch6m	9.02
Change	5.39%
Change From Open	0.64
Close	10.39
Days Gap	4.72
Depreciation Amortization	170,908.8
Dollar Volume	33,594.6
Earnings Date	2026-05-08
EBIT	$-63.4M
EBITDA	$-63.2M
EPS	$-4.38
F Score	1
FCF	$-47.9M
FCF EV Yield	-199.35x
Financing CF	57,527,518
Fiscal Year End	December
Founded	2,009
Investing CF	-1,219,263
Is Primary Listing	0
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Last Split Date	2023-02-14
Last Split Type	Reverse
Ma150	10.39
Ma150ch	5.37%
Ma20	10.28
Ma20ch	6.48%
Net CF	8,391,442
Open	10.88
Position In Range	23.72
Ppne	910,290.9
Price Date	2026-05-08
Ptbv Ratio	1.3
Relative Volume	1.87x
Share Based Comp	4,671,984
Tr6m	9.02%
Volume	3,068

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0SZI pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0SZI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0SZI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.6%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0SZI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.8

Neutral momentum band

Price vs 200-day MA

+6.6%

50/200-day relationship not available

Beta (5Y)

2.68

More volatile than the market

Sharpe ratio

0.84

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0SZI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0SZI stock rating?

lon/0SZI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0SZI analysis?

The full report lives at /stocks/lon/0SZI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0SZI?

The latest report frames lon/0SZI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0SZI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.